| abstract |
Compounds of formula I and their pharmaceutically acceptable salts and pro-drugs are provided, wherein W, R1, R2, R7, R8, R9 and R10 are defined herein. Such compounds are MEK inhibitors useful in the treatment of hyperproliferative diseases such as cancer and inflammation in mammals. A method of using the compounds in the treatment of hyperproliferative diseases in mammals and in pharmaceutical compositions containing such products is also presented. |